SCHEMBL20099796

SCHEMBL20099796

OCCCCc1ncccc1F

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.44
KDM4E B2RXH2 6/20 0.44
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 1/20 0.41
KDM1A O60341 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HSD17B10 Q99714 1/20 0.36
MAPK14 Q16539 1/20 0.35
TBXAS1 P24557 2/20 0.34
CNR2 P34972 1/20 0.34
GCK P35557 1/20 0.34
MPI P34949 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
HRH1 P35367 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20099885 0.94 CXCR4 (0.49) CXCR4KDM4EL3MBTL1ALDH1A1KDM1A
SCHEMBL5728737 0.86 L3MBTL1 (0.45) CXCR4KDM4EL3MBTL1ALDH1A1KDM1A
SCHEMBL11218925 0.83 HRH1 (0.50) CXCR4KDM1AMAOAMAOBHRH1
SCHEMBL6668385 0.81 TDP1 (0.49) CXCR4KDM4EL3MBTL1KDM1AMAOA
SCHEMBL2096356 0.81 KDM1A (0.40) CXCR4KDM4EL3MBTL1ALDH1A1KDM1A
SCHEMBL26931374 0.81 CYP2A6 (0.48) CXCR4KDM4EL3MBTL1ALDH1A1KDM1A
SCHEMBL19304381 0.80 TDP1 (0.47) KDM4EL3MBTL1KDM1AMAOAMAOB
SCHEMBL5452167 0.80 TDP1 (0.47) KDM4EL3MBTL1KDM1AMAOAMAOB
SCHEMBL22166126 0.80 TDP1 (0.47) KDM4EL3MBTL1KDM1AMAOAMAOB
SCHEMBL21076459 0.80 TDP1 (0.47) KDM4EL3MBTL1KDM1AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3315492-B1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL (JP) 2020-09-16 EP disclosed
WO-2019072978-A1 MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS Basilea Pharmaceutica International AG (CH) 2019-04-18 WO disclosed
EP-3315492-A1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Kissei Pharmaceutical Co., Ltd. (JP) 2018-05-02 EP disclosed